1. Home
  2. AVNS vs WGS Comparison

AVNS vs WGS Comparison

Compare AVNS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$25.10

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$51.79

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNS
WGS
Founded
2014
2017
Country
United States
United States
Employees
N/A
1300
Industry
Industrial Specialties
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AVNS
WGS
Price
$25.10
$51.79
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$120.71
AVG Volume (30 Days)
1.0M
2.1M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
81.59
N/A
EPS
0.11
N/A
Revenue
$701,200,000.00
N/A
Revenue This Year
$3.28
$29.98
Revenue Next Year
$4.23
$25.92
P/E Ratio
$225.50
$1,251.58
Revenue Growth
1.95
N/A
52 Week Low
$9.30
$32.21
52 Week High
$24.91
$170.87

Technical Indicators

Market Signals
Indicator
AVNS
WGS
Relative Strength Index (RSI) 86.18 52.19
Support Level $24.60 $32.21
Resistance Level N/A $73.46
Average True Range (ATR) 0.11 3.49
MACD -0.26 2.02
Stochastic Oscillator 59.57 93.69

Price Performance

Historical Comparison
AVNS
WGS

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: